These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 11920468)

  • 1. Cyclical change of hMSH2 protein expression in normal endometrium during the menstrual cycle and its overexpression in endometrial hyperplasia and sporadic endometrial carcinoma.
    Hamid AA; Mandai M; Konishi I; Nanbu K; Tsuruta Y; Kusakari T; Kariya M; Kita M; Fujii S
    Cancer; 2002 Feb; 94(4):997-1005. PubMed ID: 11920468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium.
    Mitselou A; Ioachim E; Kitsou E; Vougiouklakis T; Zagorianakou N; Makrydimas G; Stefanaki S; Agnantis NJ
    In Vivo; 2003; 17(5):469-77. PubMed ID: 14598611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the retinoblastoma-related gene Rb2/p130 is downregulated in atypical endometrial hyperplasia and adenocarcinoma.
    Susini T; Massi D; Paglierani M; Masciullo V; Scambia G; Giordano A; Amunni G; Massi G; Taddei GL
    Hum Pathol; 2001 Apr; 32(4):360-7. PubMed ID: 11331952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptosis and apoptosis-related factors Bcl-2, Bax, tumor necrosis factor-alpha, and NF-kappaB in human endometrial hyperplasia and carcinoma.
    Vaskivuo TE; Stenbäck F; Tapanainen JS
    Cancer; 2002 Oct; 95(7):1463-71. PubMed ID: 12237915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular analysis of endometrial hyperplasia in HNPCC-suspicious patients may predict progression to endometrial carcinoma.
    Sutter C; Dallenbach-Hellweg G; Schmidt D; Baehring J; Bielau S; von Knebel Doeberitz M; Gebert J
    Int J Gynecol Pathol; 2004 Jan; 23(1):18-25. PubMed ID: 14668545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of the adult stem cell marker Musashi-1 in endometriosis and endometrial carcinoma.
    Götte M; Wolf M; Staebler A; Buchweitz O; Kelsch R; Schüring AN; Kiesel L
    J Pathol; 2008 Jul; 215(3):317-29. PubMed ID: 18473332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Proliferative activity of normal endometrial cells, endometrial hyperplasia cells and endometrial cancer cells using the monoclonal antibody to PCNA].
    Hareyama H
    Hokkaido Igaku Zasshi; 1994 Nov; 69(6):1427-1. PubMed ID: 7705752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of cold-inducible RNA-binding protein in the normal endometrium, endometrial hyperplasia, and endometrial carcinoma.
    Hamid AA; Mandai M; Fujita J; Nanbu K; Kariya M; Kusakari T; Fukuhara K; Fujii S
    Int J Gynecol Pathol; 2003 Jul; 22(3):240-7. PubMed ID: 12819390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis, bcl-2 expression, and proliferation in benign and malignant endometrial epithelium: An approach using multiparameter flow cytometry.
    Morsi HM; Leers MP; Radespiel-Tröger M; Björklund V; Kabarity HE; Nap M; Jäger W
    Gynecol Oncol; 2000 Apr; 77(1):11-7. PubMed ID: 10739685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coabnormal expression of cyclin D1 and p53 protein in human uterine endometrial carcinomas.
    Nikaido T; Li SF; Shiozawa T; Fujii S
    Cancer; 1996 Sep; 78(6):1248-53. PubMed ID: 8826947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the human mismatch repair gene hMSH2: a potential marker for urothelial malignancy.
    Leach FS; Hsieh JT; Molberg K; Saboorian MH; McConnell JD; Sagalowsky AI
    Cancer; 2000 May; 88(10):2333-41. PubMed ID: 10820356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. bcl-2 expression and the development of endometrial carcinoma.
    Chhieng DC; Ross JS; Ambros RA
    Mod Pathol; 1996 Apr; 9(4):402-6. PubMed ID: 8729980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Contribution of immunohistochemistry and flow-cytometry in the study of endometrial pathology].
    Amălinei C; Căruntu ID; Balan R; Cianga C; Cianga P
    Rev Med Chir Soc Med Nat Iasi; 2008; 112(2):437-48. PubMed ID: 19295017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of fos and jun proto-oncogenes in benign versus malignant human uterine tissue.
    Nephew KP; Choi CM; Polek TC; McBride R; Bigsby RM; Khan SA; Husseinzadeh N
    Gynecol Oncol; 2000 Mar; 76(3):388-96. PubMed ID: 10684716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomerase activity in human endometrium.
    Kyo S; Takakura M; Kohama T; Inoue M
    Cancer Res; 1997 Feb; 57(4):610-4. PubMed ID: 9044835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of replication-licensing factors MCM2 and MCM3 in normal, hyperplastic, and carcinomatous endometrium: correlation with expression of Ki-67 and estrogen and progesterone receptors.
    Kato K; Toki T; Shimizu M; Shiozawa T; Fujii S; Nikaido T; Konishi I
    Int J Gynecol Pathol; 2003 Oct; 22(4):334-40. PubMed ID: 14501812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
    Parekh TV; Gama P; Wen X; Demopoulos R; Munger JS; Carcangiu ML; Reiss M; Gold LI
    Cancer Res; 2002 May; 62(10):2778-90. PubMed ID: 12019154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endometrial TIMP-4 mRNA is high at midcycle and in hyperplasia, but down-regulated in malignant tumours. Coordinated expression with MMP-26.
    Pilka R; Domanski H; Hansson S; Eriksson P; Casslén B
    Mol Hum Reprod; 2004 Sep; 10(9):641-50. PubMed ID: 15273280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear localization of beta-catenin in normal and carcinogenic endometrium.
    Nei H; Saito T; Yamasaki H; Mizumoto H; Ito E; Kudo R
    Mol Carcinog; 1999 Jul; 25(3):207-18. PubMed ID: 10411147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human mismatch repair gene (hMSH2) product expression in relation to recurrence of transitional cell carcinoma of the urinary bladder.
    Jin TX; Furihata M; Yamasaki I; Kamada M; Liang SB; Ohtsuki Y; Shuin T
    Cancer; 1999 Jan; 85(2):478-84. PubMed ID: 10023718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.